Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice.

MDSCs SKG mice arthritis microarray osteoclastogenesis

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2024
Historique:
received: 20 02 2023
accepted: 13 02 2024
medline: 3 4 2024
pubmed: 3 4 2024
entrez: 3 4 2024
Statut: epublish

Résumé

Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells with immunosuppressive functions. It is known that MDSCs are expanded at inflammatory sites after migrating from bone marrow (BM) or spleen (Sp). In chronic inflammatory diseases such as rheumatoid arthritis (RA), previous reports indicate that MDSCs are increased in BM and Sp, but detailed analysis of MDSCs in inflamed joints is very limited. The purpose of this study is to characterize the MDSCs in the joints of mice with autoimmune arthritis. We sorted CD11b We identified MDSCs as CD11b Jo-MDSCs possess a potential to differentiate into osteoclasts which promote bone resorption in inflamed joints, while they are immunosuppressive

Sections du résumé

Background UNASSIGNED
Myeloid-derived suppressor cells (MDSCs) are heterogeneous immature myeloid cells with immunosuppressive functions. It is known that MDSCs are expanded at inflammatory sites after migrating from bone marrow (BM) or spleen (Sp). In chronic inflammatory diseases such as rheumatoid arthritis (RA), previous reports indicate that MDSCs are increased in BM and Sp, but detailed analysis of MDSCs in inflamed joints is very limited.
Objective UNASSIGNED
The purpose of this study is to characterize the MDSCs in the joints of mice with autoimmune arthritis.
Methods UNASSIGNED
We sorted CD11b
Results UNASSIGNED
We identified MDSCs as CD11b
Conclusions UNASSIGNED
Jo-MDSCs possess a potential to differentiate into osteoclasts which promote bone resorption in inflamed joints, while they are immunosuppressive

Identifiants

pubmed: 38566990
doi: 10.3389/fimmu.2024.1168323
pmc: PMC10985135
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1168323

Informations de copyright

Copyright © 2024 Fujikawa, Sendo, del Peral Fanjul, Yamada, Uto, Yamamoto, Nagamoto, Morinobu and Saegusa.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Yoshikazu Fujikawa (Y)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Sho Sendo (S)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Alfonso Del Peral Fanjul (A)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Hirotaka Yamada (H)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Kenichi Uto (K)

Department of Clinical Laboratory, Kobe University Graduate School of Medicine, Kobe, Japan.

Yuzuru Yamamoto (Y)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Takumi Nagamoto (T)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Akio Morinobu (A)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.
Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Jun Saegusa (J)

Department of Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan.

Classifications MeSH